Biosig Technologies Inc
NASDAQ:BSGM
Intrinsic Value
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the f... [ Read More ]
The intrinsic value of one BSGM stock under the Base Case scenario is 1.533 USD. Compared to the current market price of 1.555 USD, Biosig Technologies Inc is Overvalued by 1%.
Valuation Backtest
Biosig Technologies Inc
Run backtest to discover the historical profit from buying and selling BSGM stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Biosig Technologies Inc
Current Assets | 1.1m |
Cash & Short-Term Investments | 490k |
Receivables | 10k |
Other Current Assets | 550k |
Non-Current Assets | 2.1m |
Long-Term Investments | 40k |
PP&E | 1.1m |
Intangibles | 290k |
Other Non-Current Assets | 690k |
Current Liabilities | 3.9m |
Accrued Liabilities | 3.8m |
Other Current Liabilities | 100k |
Non-Current Liabilities | 300k |
Other Non-Current Liabilities | 300k |
Earnings Waterfall
Biosig Technologies Inc
Revenue
|
150k
USD
|
Cost of Revenue
|
-40k
USD
|
Gross Profit
|
110k
USD
|
Operating Expenses
|
-29.5m
USD
|
Operating Income
|
-29.4m
USD
|
Other Expenses
|
-700k
USD
|
Net Income
|
-30.1m
USD
|
Free Cash Flow Analysis
Biosig Technologies Inc
What is Free Cash Flow?
BSGM Profitability Score
Profitability Due Diligence
Biosig Technologies Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
Biosig Technologies Inc's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
BSGM Solvency Score
Solvency Due Diligence
Biosig Technologies Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Score
Biosig Technologies Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
BSGM Price Targets Summary
Biosig Technologies Inc
Ownership
BSGM Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
BSGM Price
Biosig Technologies Inc
Average Annual Return | -40.82% |
Standard Deviation of Annual Returns | 31.44% |
Max Drawdown | -99% |
Market Capitalization | 14.5m USD |
Shares Outstanding | 9 334 640 |
Percentage of Shares Shorted | 8.9% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. The company is headquartered in Westport, Connecticut and currently employs 50 full-time employees. The company went IPO on 2014-09-22. The firm is focused on providing intracardiac signal information to electrophysiologists during electrophysiology (EP) studies and cardiac catheter ablation procedures for atrial fibrillation (AF) and ventricular tachycardia (VT). The firm is commercializing its PURE EP System, which is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures, such as environmental lab noise, signal saturation, slow signal recovery, and inaccurate display of fractionated potentials. PURE EP is a signal processing platform that combines hardware and software to address known challenges associated with signal acquisition, to enable electrophysiologists to see more signals and analyze them in real-time. The device aims to minimize noise and artifacts from cardiac recordings and acquire high-fidelity cardiac signals.
Contact
IPO
Employees
Officers
The intrinsic value of one BSGM stock under the Base Case scenario is 1.533 USD.
Compared to the current market price of 1.555 USD, Biosig Technologies Inc is Overvalued by 1%.